Aurora Cannabis Inc. (NASDAQ:ACB) is among the 12 Best Marijuana Stocks to Buy According to Analysts. Aurora Cannabis Inc. (NASDAQ:ACB) and German healthcare technology company Copeia have released an English-language version of the Physician Experience Platform (PEP). The platform has over 130 anonymized case studies detailing real-world medicinal cannabis treatments, including patient history, symptoms, dose, outcomes, and concurrent medicines. PEP, which is initially available in Canada, the United Kingdom, Poland, Malta, the Czech Republic, Australia, and New Zealand, intends to provide healthcare professionals with access to peer-reviewed clinical insights. Aurora Cannabis Inc. (NASDAQ:ACB)’s Director of Medical & Patient Affairs, Dr. Stephanie Lunn, stated that the launch “sets a new standard in peer-led clinical knowledge sharing.”Aurora And Copeia Launches English-language version of the Physician Experience Platform (PEP)

Stokkete/Shutterstock.com

PEP builds on the successful German launch in 2024 and is protected by a DocCheck login for verified physicians. The firm intends to create an international medical cannabis case study database that will enable physicians from around the world to upload cases in the future. Aurora Cannabis Inc. (NASDAQ:ACB) operates in the global medicinal and consumer cannabis markets under names such as MedReleaf, CanniMed, Drift, and San Rafael ’71. It is one of the Best Marijuana Stocks.

While we acknowledge the potential of ACB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025.

Disclosure. None.

View Comments